KEGG: osa:4338605
STRING: 39947.LOC_Os05g31040.1
CKX9 (cytokinin oxidase/dehydrogenase 9, UniProt: Q75K78) is an enzyme in rice that plays a crucial role in cytokinin metabolism. This enzyme catalyzes the irreversible degradation of cytokinins, which are plant hormones involved in numerous developmental processes. CKX9 antibodies facilitate the study of cytokinin regulation pathways in rice, allowing researchers to investigate how this enzyme influences developmental patterns, stress responses, and crop yield potential. Understanding CKX9 expression and activity contributes significantly to research on rice growth regulation and potential yield improvements.
Rigorous validation of CKX9 antibody specificity is essential for reliable experimental results. Recommended methods include:
Western blotting comparing wild-type samples with CKX9 knockdown/knockout tissues
Peptide competition assays using the antigenic peptide to which the antibody was raised
Comparison with alternative CKX9 antibodies from different sources or clones
Immunoprecipitation followed by mass spectrometry to verify target capture
Testing the antibody against recombinant CKX9 protein and closely related CKX family members
For CKX9 antibody from CUSABIO (CSB-PA741696XA01OFG), researchers should perform these validations within their specific experimental conditions as part of standard quality control procedures .
To maintain antibody integrity and performance, CKX9 antibody requires:
Storage at -20°C for long-term preservation or at 4°C for up to one month during active use
Avoidance of repeated freeze-thaw cycles (recommend aliquoting upon first thaw)
Protection from direct light exposure
Gentle mixing by inversion rather than vortexing to prevent protein denaturation
Centrifugation before use if precipitation is observed
Use of appropriate stabilizing buffers if dilution is necessary (typically PBS with 0.1% BSA)
These conditions help preserve antibody functionality, particularly for sensitive applications such as immunoprecipitation or immunohistochemistry .
Optimizing Western blot protocols for CKX9 detection requires systematic assessment of several parameters:
Sample preparation: Extraction buffers containing protease inhibitors are crucial, with RIPA buffer (supplemented with 1mM PMSF and protease inhibitor cocktail) typically yielding good results for membrane-associated proteins like CKX9
Protein loading: 20-50μg total protein per lane, with precise quantification
Transfer conditions: Semi-dry transfer at 15V for 1 hour or wet transfer at 30V overnight at 4°C
Blocking: 5% non-fat dry milk in TBST for 1-2 hours at room temperature
Primary antibody: Initial testing at 1:500-1:2000 dilution range in TBST with 1% BSA
Washing: 5-6 washes with TBST, 5 minutes each
Secondary antibody: Anti-species IgG-HRP at 1:5000-1:10000
Detection: Enhanced chemiluminescence with exposure time optimization
Each parameter should be systematically tested and documented to establish reproducible results for CKX9 detection in specific rice tissue types .
Comprehensive experimental controls for CKX9 antibody applications include:
Positive control: Known CKX9-expressing tissue (e.g., young rice stems)
Negative control:
Tissues with confirmed low/no CKX9 expression
CKX9 knockout/knockdown samples where available
Technical controls:
Primary antibody omission
Isotype control (non-targeted antibody of same isotype)
Secondary antibody only
Loading controls: Housekeeping proteins appropriate for the specific tissue/treatment
Expression reference: Recombinant CKX9 protein at known concentrations
These controls help identify non-specific binding, validate signal specificity, and enable accurate quantification across experiments .
Successful immunohistochemistry for CKX9 localization in rice tissues requires:
Tissue fixation: 4% paraformaldehyde in PBS for 24 hours, with careful monitoring of pH
Sectioning: 5-10μm sections on positively charged slides
Antigen retrieval: Heat-induced epitope retrieval using citrate buffer (pH 6.0)
Permeabilization: 0.1% Triton X-100 in PBS for 10-15 minutes
Blocking: 5% normal serum (from species of secondary antibody) with 1% BSA
Primary antibody: CKX9 antibody at 1:100-1:500 dilution, incubated overnight at 4°C
Detection system: Fluorescent or HRP-conjugated secondary antibodies
Counterstaining: DAPI for nuclei visualization
Mounting: Anti-fade mounting medium
This protocol should be optimized for specific tissue types, with particular attention to antigen retrieval conditions which often determine detection sensitivity .
When encountering cross-reactivity with CKX9 antibody (CSB-PA741696XA01OFG), researchers should implement these troubleshooting approaches:
Antibody titration: Test serial dilutions (1:100 to 1:5000) to identify optimal signal-to-noise ratio
Buffer optimization: Modify blocking agents (milk vs. BSA vs. normal serum) and detergent concentrations
Pre-adsorption: Pre-incubate antibody with rice tissue lysate from CKX9-deficient samples
Alternative blocking: Use commercial blocking solutions specifically designed for plant tissues
Cross-reactivity analysis: Perform Western blots against recombinant CKX family proteins (CKX1-8) to assess binding specificity
Epitope analysis: Compare the immunogen sequence against other rice proteins using bioinformatics tools
Documenting these optimization steps is essential for method reproducibility and publication standards .
Accurate quantification of CKX9 protein levels requires:
Appropriate loading controls selection:
ACTIN, TUBULIN, or GAPDH for general tissue analysis
Membrane proteins like H+-ATPase for membrane-enriched fractions
Nuclear proteins like Histone H3 for nuclear fractions
Normalization approaches:
Band intensity ratio (CKX9/loading control) using densitometry software
Relative quantification against a reference sample
Absolute quantification using recombinant CKX9 standard curve
Statistical analysis:
Minimum of three biological replicates
Appropriate statistical tests based on data distribution
Reporting both mean values and measures of dispersion
Data presentation recommendations:
Bar graphs with error bars
Inclusion of representative blot images
Clear indication of sample identity and experimental conditions
This systematic approach ensures reliable interpretation of CKX9 expression data across different experimental conditions .
Interpreting developmental patterns of CKX9 expression requires consideration of:
Tissue-specific expression profiles:
Meristematic regions often show distinct expression patterns
Vascular tissues may have specialized localization
Reproductive tissues can exhibit stage-specific regulation
Developmental timing factors:
Precise staging using standardized developmental markers
Correlation with key developmental transitions
Comparison with other CKX family members (CKX1-8)
Environmental influence assessment:
Growth conditions documentation (light, temperature, nutrients)
Stress exposure history
Circadian rhythm considerations
Interpretation challenges:
Post-translational modifications affecting antibody recognition
Protein turnover rates vs. steady-state levels
Potential disconnect between protein levels and enzymatic activity
Researchers should document these variables comprehensively to enable meaningful interpretation of developmental expression patterns .
While CKX9 is primarily a cytokinin-degrading enzyme rather than a transcription factor, ChIP applications might be relevant for studying potential nuclear interactions or regulatory complexes. For such specialized applications:
Crosslinking optimization:
Test formaldehyde concentrations (0.5-2%)
Evaluate crosslinking times (5-20 minutes)
Consider dual crosslinking with DSG followed by formaldehyde for complex stabilization
Sonication parameters:
Optimize sonication conditions (amplitude, cycle number, duration)
Aim for chromatin fragments of 200-500bp
Verify fragmentation by agarose gel electrophoresis
Immunoprecipitation considerations:
Protein A/G beads pre-clearing step
CKX9 antibody amounts (2-10μg per reaction)
Extended incubation times (overnight at 4°C)
Controls requirement:
Input samples (5-10% pre-IP chromatin)
IgG control immunoprecipitation
Positive control loci for known interacting proteins
This specialized application requires extensive optimization and validation for meaningful results .
To investigate CKX9 interaction partners, researchers can employ these methodologies:
Co-immunoprecipitation (Co-IP):
Use CKX9 antibody (CSB-PA741696XA01OFG) for pull-down experiments
Optimize lysis buffers to maintain interactions (typically lower detergent)
Analyze precipitated complexes by mass spectrometry
Validate interactions by reciprocal Co-IP
Proximity labeling approaches:
BioID or TurboID fusion with CKX9
APEX2-based proximity labeling
Expression in rice protoplasts or transgenic plants
In vitro interaction studies:
Pull-down assays with recombinant proteins
Surface plasmon resonance for binding kinetics
Yeast two-hybrid screening with CKX9 as bait
Visualization of interactions:
Bimolecular fluorescence complementation (BiFC)
Förster resonance energy transfer (FRET)
Split luciferase complementation assays
These methods provide complementary information about CKX9's interaction network and functional associations in cytokinin metabolism pathways .
Inconsistent CKX9 antibody performance may stem from several factors:
| Problem | Potential Causes | Solutions |
|---|---|---|
| Weak or no signal | Protein degradation | Add fresh protease inhibitors, process samples on ice |
| Insufficient antibody concentration | Increase antibody concentration, extend incubation time | |
| Poor transfer efficiency | Optimize transfer time/voltage, check transfer efficiency with staining | |
| Epitope masking | Try different antigen retrieval methods | |
| High background | Insufficient blocking | Increase blocking time, try alternative blocking agents |
| Excessive antibody concentration | Titrate antibody, increase washing steps | |
| Non-specific binding | Pre-adsorb antibody, use more stringent washing buffers | |
| Inconsistent bands | Post-translational modifications | Use phosphatase inhibitors, investigate specific modifications |
| Sample preparation variability | Standardize extraction protocol, quantify proteins accurately | |
| Splice variants | Design experiments to distinguish variants, use complementary methods |
Systematic documentation of conditions and results is essential for identifying the sources of inconsistency and developing stable protocols .
CKX9 detection in specific subcellular compartments requires protocol adaptations:
Membrane-enriched fractions:
Use detergent-based extraction buffers (e.g., 1% Triton X-100)
Include sucrose gradient purification steps
Verify fraction purity with membrane marker proteins
Cytosolic fraction:
Employ gentle lysis buffers without detergents
Remove membrane components by ultracentrifugation
Confirm with cytosolic markers (e.g., GAPDH)
Nuclear extracts:
Use specialized nuclear extraction kits
Verify nuclear integrity during extraction
Check for cytoplasmic contamination
Immunofluorescence adaptations:
Co-staining with compartment-specific markers
Super-resolution microscopy for precise localization
Z-stack imaging for complete spatial assessment
These methodological adaptations enable accurate assessment of CKX9 distribution across cellular compartments, providing insights into its functional domains within rice cells .
CKX9 antibody enables several approaches to investigate stress-induced cytokinin regulation:
Stress response profiling:
Monitor CKX9 protein levels during drought, salt, temperature stresses
Compare expression patterns across stress-tolerant and susceptible varieties
Correlate CKX9 levels with cytokinin content using complementary techniques
Experimental design considerations:
Time-course sampling to capture dynamic responses
Tissue-specific analysis (roots vs. shoots)
Controlled stress application protocols
Standardized physiological measurements
Multi-omics integration:
Combine protein data with transcriptomics and metabolomics
Correlate CKX9 protein levels with CKX9 transcript abundance
Integrate with cytokinin quantification data
Functional validation approaches:
Transgenic studies with modified CKX9 expression
Enzyme activity assays correlated with protein levels
Spatial localization during stress responses
These approaches can reveal how cytokinin degradation contributes to stress adaptation mechanisms in rice .
When using CKX9 antibody in transgenic research contexts, consider:
Epitope preservation verification:
Confirm antibody recognition of modified/tagged CKX9 proteins
Test antibody against the specific fusion protein or modified variant
Consider epitope location relative to introduced modifications
Expression level assessment:
Develop quantitative standard curves using recombinant protein
Compare endogenous vs. transgenic protein levels
Account for potential feedback regulation of native CKX9
Technical validation:
Multiple independent transgenic lines analysis
Comparison across different promoters/expression systems
Correlation with phenotypic observations
Verification with alternative detection methods
Controls for transgenic studies:
Empty vector transformants
Segregating wild-type siblings
Transgenic lines expressing unrelated proteins
These considerations ensure reliable interpretation of transgenic studies where CKX9 has been modified, overexpressed, or suppressed .